CD38 Glycosylation Determines Antibody Recognition in Myeloid Leukemia Cell Lines

被引：0
|
作者：
Steenackers, Agata [1 ]
Rosenbalm, Katelyn E. [1 ]
Weich, Natalia [1 ]
Hoffmeister, Karin M. [1 ,2 ,3 ]
机构：
[1] Versiti Blood Res Inst, Translat Glyc Ctr, Milwaukee, WI USA
[2] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI USA
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI USA
来源：
GLYCOBIOLOGY | 2023年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P192
引用
收藏
页码：1045 / 1045
页数：1
相关论文
共 50 条
  • [21] CD9 and CD38 Expressions Are Significantly Associated with Outcome in Adult Acute Myeloid Leukemia
    Swati, I. N.
    Islam, H. K.
    Rasul, M.
    LABORATORY INVESTIGATION, 2010, 90 : 323A - 324A
  • [22] CD38 knocKout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide
    Gurney, Mark
    Stikvoort, Arwen
    Nolan, Emma
    Kirkham-McCarthy, Lucy
    Khoruzhenko, Stanislav
    Shivakumar, Rama
    Zweegman, Sonja
    Van de Donk, Niels W. C. J.
    Mutis, Tuna
    Szegezdi, Eva
    Sarkar, Subhashis
    O'Dwyer, Michael
    HAEMATOLOGICA, 2022, 107 (02) : 437 - 445
  • [23] ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary
    Congleton, Johanna
    Jiang, Hong
    Malavasi, Fabio
    Lin, Hening
    Yen, Andrew
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (07) : 910 - 919
  • [24] CD9 and CD38 Expressions Are Significantly Associated with Outcome In Adult Acute Myeloid Leukemia
    Swati, I. N.
    Islam, H. K.
    Rasul, M.
    MODERN PATHOLOGY, 2010, 23 : 323A - 324A
  • [25] INHIBITORY EFFECT OF THE ANTIBODY TO CD34 MOLECULE ON STEM CELL AND MYELOID LEUKEMIA CELL LINES
    Stockbauer, P.
    Elknerova, K.
    Lacinova, Z.
    Soucek, J.
    Nemcova, J.
    Schwarz, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 571 - 571
  • [26] Isatuximab - A CD38 Antibody with specific Activity
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (7-8) : 421 - 421
  • [27] CD38 Variation in Chronic Lymphocytic Leukemia
    Nipp, Ryan D.
    Weinberg, J. Brice
    Volkheimer, Alicia D.
    Davis, Evan D.
    Chen, Youwei
    Friedman, Daphne R.
    BLOOD, 2012, 120 (21)
  • [28] Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
    Plesner, Torben
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    CELLS, 2020, 9 (02)
  • [29] Investigating the Dual Targeting of BCL-2 and CD38 in Models of Acute Myeloid Leukemia
    Mistry, Jayna J.
    Hellmich, Charlotte
    Lambert, Amelia
    Moore, Jamie A.
    Jibril, Aisha
    Collins, Angela
    Di Palma, Federica
    Bowles, Kristian M.
    Rushworth, Stuart A.
    BLOOD, 2020, 136
  • [30] Retinoid-mediated signaling pathways in CD38 antigen expression in myeloid leukemia cells
    Mehta, K
    Cheema, S
    LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) : 441 - +
12345